We Announce our Role as Advisor to Sagard NewGen

News
Category:
Published on:
September 11, 2020

Alira Health is pleased to announce its role as Advisor to Sagard NewGen for the equity investment in Laboratoires Delbert. This recent capital raise of €40m supports the company’s growth strategy and mission of keeping essential medicinal products on the market and available to patients around the world.

For more information, please contact Benjamin Chambon.

 

For more information about Alira Health’s Transaction Advisory practice

Click here

Related news

M&A
Publications February 28, 2021
What’s most important when selecting a firm for your next transaction?
M&A
Publications February 24, 2021
What You Should Know Before Choosing a Healthcare Transaction Advisory Firm
What’s most important when selecting a firm for your next transaction? Global experience, staff profiles, technical expertise? To learn more download our latest TAD Infographic.
M&A Pharma
News December 20, 2020
We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS
We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.
M&A
News November 29, 2020
We Announce our Role as Strategic Advisor to Benvic in the Acquisition of Luc & Bel
We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel.
M&A
Publications November 1, 2020
Five Key Success Factors for Managing Transactions in Full Virtual Mode
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
M&A MedTech
Publications October 10, 2020
Q3 2020 Medical Device Contract Development and Manufacturing M&A Report
Despite the COVID-19 pandemic, M&A activity in the global CDMO industry has been exceptionally strong in 2020 with a record number of transactions completed during the third quarter alone.
M&A
News August 20, 2020
We Announce our Role as Exclusive Strategic Advisor to AGC Biologics in its Acquisition of MolMed SpA
We are proud to announce our role as strategic advisor to AGC Biologics, a leading global biopharmaceutical contract development, and manufacturing organization, in their acquisition(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.